PDL – Depomed’s deal for type 2 diabetes products
PDL BioPharma, Inc. (PDL) announces an amendment to the Royalty Purchase and Sale Agreement (the “Royalty Agreement”) with Depomed, Inc. (Depome”) under... Read More
Depomed buys suite of Janssen pain drugs for $1bn
Posted on19 Jan 2015
Comments0
Tapentadol is a centrally acting analgesic with a dual mode of action as an agonist of the μ-opioid receptor and as a norepinephrine... Read More